Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | PKM | P14618 | 2/20 | 0.44 |
| ▸ | ALPI | P09923 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | XIAP | P98170 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | BLM | P54132 | 2/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | RGS12 | O14924 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2451002 | 1.00 | SLC7A5 (0.49) | SLC7A5CYP3A4PKMALPIPTGS1 | |
| SCHEMBL23356093 | 1.00 | SLC7A5 (0.49) | SLC7A5CYP3A4PKMALPIPTGS1 | |
| SCHEMBL2059137 | 0.81 | ALDH1A1 (0.37) | SLC7A5CYP3A4ALDH1A1 | |
| Hydrochloric Acid SCHEMBL5814493 | 0.80 | ALDH1A1 (0.39) | SLC7A5CYP3A4ALDH1A1 | |
| SCHEMBL21689933 | 0.75 | SLC7A5 (0.53) | SLC7A5CYP3A4PKMALPIPTGS1 | |
| SCHEMBL1769036 | 0.75 | SLC7A5 (0.53) | SLC7A5CYP3A4PKMALPIPTGS1 | |
| SCHEMBL1769034 | 0.75 | SLC7A5 (0.53) | SLC7A5CYP3A4PKMALPIPTGS1 | |
| Hydrochloric Acid SCHEMBL20502478 | 0.73 | SLC7A5 (0.52) | SLC7A5CYP3A4PKMALPIPTGS1 | |
| SCHEMBL5828934 | 0.73 | KIF11 (0.38) | SLC7A5CYP3A4 | |
| SCHEMBL1891367 | 0.70 | GRIA2 (0.50) | SLC7A5CYP3A4PKMALPIPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 615 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240350681-A1 | RADIOLABELED MELANOCORTIN 1 RECEPTOR-SPECIFIC ALPHA-MELANOCYTE-STIMULATING HORMONE ANALOGUES FOR IMAGING OR THERAPY | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2024-10-24 | — | — | US | claimed |
| US-11992537-B2 | Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2024-05-28 | — | — | US | claimed |
| US-20210205483-A1 | RADIOLABELED MELANOCORTIN 1 RECEPTOR-SPECIFIC ALPHA-MELANOCYTE-STIMULATING HORMONE ANALOGUES FOR IMAGING OR THERAPY | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2021-07-08 | — | — | US | claimed |
| EP-3820886-A1 | RADIOLABELED MELANOCORTIN 1 RECEPTOR-SPECIFIC ALPHA-MELANOCYTE-STIMULATING HORMONE ANALOGUES FOR IMAGING OR THERAPY | Provincial Health Services Authority (CA) | 2021-05-19 | — | — | EP | claimed |
| US-20170022487-A1 | SYNTHETIC CATALYTIC MIMICS OF ESTERASES, LIPASES OR DESATURASES | UNIV CALIFORNIA (US) | 2017-01-26 | — | — | US | claimed |
| WO-2015153730-A2 | SYNTHETIC CATALYTIC MIMICS OF ESTERASES, LIPASES OR DESATURASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-10-08 | — | — | WO | claimed |
| US-20150175993-A1 | NOVEL SYNZYMES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2015-06-25 | — | — | US | claimed |
| EP-2864349-A2 | DYNAMIC BIOMIMETIC SYNZYME CATALYST, CATALYSIS, AND CATALYTIC SYSTEMS | The Regents of The University of California (US) | 2015-04-29 | — | — | EP | claimed |
| WO-2013192430-A2 | DYNAMIC BIOMIMETIC SYNZYME CATALYST, CATALYSIS, AND CATALYTIC SYSTEMS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-12-27 | — | — | WO | claimed |
| US-20130029426-A1 | Dual Inducible System for the cSPP System | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2013-01-31 | — | — | US | claimed |
| US-20090035836-A1 | MODULATING PH-SENSITIVE BINDING USING NON-NATURAL AMINO ACIDS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2009-02-05 | — | — | US | claimed |
| US-20050260711-A1 | Modulating pH-sensitive binding using non-natural amino acids | CALIFORNIA INSITUTE OF TECHNOLOGY | 2005-11-24 | — | — | US | claimed |
| EP-0777458-B1 | CONTROL OF HAIR GROWTH | UNIV SHEFFIELD (GB) | 2000-12-06 | — | — | EP | claimed |
| US-6020327-A | Control of hair growth | THE CENTRAL SHEFFIELD UNIVERSITY HOSPITALS NHS TRUST (GB) | 2000-02-01 | — | — | US | claimed |
| EP-0136359-B1 | PROCESS FOR PREPARING L-HISTIDINE | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) | 1991-04-03 | — | — | EP | claimed |
| EP-0136359-A1 | PROCESS FOR PREPARING L-HISTIDINE | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) | 1985-04-10 | — | — | EP | claimed |
| JP-60210994-A | — | — | None | — | — | JP | disclosed |
| US-12616761-B2 | CXCR4-targeting compounds | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2026-05-05 | — | — | US | disclosed |
| JP-S60210994-A | PREPARATION OF HISTIDINE | KYOWA HAKKO KOGYO CO LTD | 1985-10-23 | — | — | JP | disclosed |
| EP-0136359-A1 | PROCESS FOR PREPARING L-HISTIDINE | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) | 1985-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11992537-B2 | Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy | MC1R, MC5R, MC3R | SLC7A5 200/4885CYP3A4 4044/4885PKM 3481/4885 |
| US-20050260711-A1 | Modulating pH-sensitive binding using non-natural amino acids | AARS1, TARBP1, NSUN3 | SLC7A5 34/4885CYP3A4 4881/4885PKM 1826/4885 |
| US-20090035836-A1 | MODULATING PH-SENSITIVE BINDING USING NON-NATURAL AMINO ACIDS | AARS1, TARBP1, NSUN3 | SLC7A5 34/4885CYP3A4 4881/4885PKM 1826/4885 |
| US-20210205483-A1 | RADIOLABELED MELANOCORTIN 1 RECEPTOR-SPECIFIC ALPHA-MELANOCYTE-STIMULATING HORMONE ANALOGUES FOR IMAGING OR THERAPY | MC1R, MC5R, MC3R | SLC7A5 200/4885CYP3A4 4044/4885PKM 3481/4885 |
| US-12616761-B2 | CXCR4-targeting compounds | CXCR4, CXCR2, CXCR3 | SLC7A5 354/4885CYP3A4 4779/4885PKM 4002/4885 |
| US-20240350681-A1 | RADIOLABELED MELANOCORTIN 1 RECEPTOR-SPECIFIC ALPHA-MELANOCYTE-STIMULATING HORMONE ANALOGUES FOR IMAGING OR THERAPY | MC1R, MC3R, MC5R | SLC7A5 196/4885CYP3A4 3979/4885PKM 3504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.